This module enables investors to look at IQVIA Holdings various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing IQVIA Holdings Valuation or Volatility. It can also complement various IQVIA Holdings Technical models. Additionally take a look at Your Equity Center.
Cash and Equivalents AnalysisCash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
About Cash and EquivalentsCash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).Compare to competition
In accordance with recently published financial statements IQVIA Holdings has 1.15 B in Cash and Equivalents. This is 32.17% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceuticals And Biosciences industry, The Cash and Equivalents for all stocks is 70.45% higher than the company.